Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroshi Hoshiai

Showing results (1-10 of 66) with videos related to

Pageof 7
Sort By:
Drugs of Today (Barcelona, Spain : 1998)|October 4, 2005
Current guidelines for treatment of endometriosis. The present status in JapanHiroshi Hoshiai
Gynecologic and Obstetric Investigation|October 24, 2008
Novel therapeutic targets for GnRH analogues in the treatment of endometriosis and current approaches to optimizing GnRH analogue therapy. IntroductionHiroshi Hoshiai, Naoki Terakawa
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 13, 2004
[Recent outline of chemotherapy for uterine endometrial cancer]Yoh Watanabe, Hiroshi Hoshiai
The Journal of Obstetrics and Gynaecology Research|May 10, 2012
Retrospective evaluation of tumor markers in ovarian mature cystic teratoma and ovarian endometriomaTaeko Kataoka, Yoh Watanabe, Hiroshi Hoshiai
Current Medical Research and Opinion|April 7, 2005
The effect of granisetron on in vitro metabolism of doxorubicin, irinotecan and etoposideYoh Watanabe, Hidekatsu Nakai, Hiroshi Hoshiai
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 13, 2004
[Hemoglobin level and recurrent rate of uterine cervical cancer]Haruhiko Ueda, Yoh Watanabe, Hiroshi Hoshiai
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 20, 2012
[Current treatment strategy of sex cord--stromal tumors of the ovary by molecular targeted therapy]Yoh Watanabe, Yuka Ekawa, Hiroshi Hoshiai
Fertility and Sterility|October 10, 2019
Relugolix, a novel oral gonadotropin-releasing hormone antagonist, in the treatment of pain symptoms associated with uterine fibroids: a randomized, placebo-controlled, phase 3 study in Japanese womenYutaka Osuga, Kazuaki Enya, Kentarou Kudou, et al.
The Journal of Obstetrics and Gynaecology Research|August 11, 2007
Definitive diagnosis of primary adenocarcinoma of the appendix by laparoscopic appendectomyMasahiko Umemoto, Mitsuru Shiota, Masao Shimaoka, et al.
Cancer Letters|January 12, 2007
Hypoxia inducible factor 1-alpha expression as a factor predictive of efficacy of taxane/platinum chemotherapy in advanced primary epithelial ovarian cancerHidekatsu Nakai, Yoh Watanabe, Haruhiko Ueda, et al.
Pageof 7

Showing results (1-10 of 66) with videos related to

Sort By:
Pageof 7
Drugs of Today (Barcelona, Spain : 1998)|October 4, 2005
Current guidelines for treatment of endometriosis. The present status in JapanHiroshi Hoshiai
Gynecologic and Obstetric Investigation|October 24, 2008
Novel therapeutic targets for GnRH analogues in the treatment of endometriosis and current approaches to optimizing GnRH analogue therapy. IntroductionHiroshi Hoshiai, Naoki Terakawa
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 13, 2004
[Recent outline of chemotherapy for uterine endometrial cancer]Yoh Watanabe, Hiroshi Hoshiai
The Journal of Obstetrics and Gynaecology Research|May 10, 2012
Retrospective evaluation of tumor markers in ovarian mature cystic teratoma and ovarian endometriomaTaeko Kataoka, Yoh Watanabe, Hiroshi Hoshiai
Current Medical Research and Opinion|April 7, 2005
The effect of granisetron on in vitro metabolism of doxorubicin, irinotecan and etoposideYoh Watanabe, Hidekatsu Nakai, Hiroshi Hoshiai
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 13, 2004
[Hemoglobin level and recurrent rate of uterine cervical cancer]Haruhiko Ueda, Yoh Watanabe, Hiroshi Hoshiai
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 20, 2012
[Current treatment strategy of sex cord--stromal tumors of the ovary by molecular targeted therapy]Yoh Watanabe, Yuka Ekawa, Hiroshi Hoshiai
Fertility and Sterility|October 10, 2019
Relugolix, a novel oral gonadotropin-releasing hormone antagonist, in the treatment of pain symptoms associated with uterine fibroids: a randomized, placebo-controlled, phase 3 study in Japanese womenYutaka Osuga, Kazuaki Enya, Kentarou Kudou, et al.
The Journal of Obstetrics and Gynaecology Research|August 11, 2007
Definitive diagnosis of primary adenocarcinoma of the appendix by laparoscopic appendectomyMasahiko Umemoto, Mitsuru Shiota, Masao Shimaoka, et al.
Cancer Letters|January 12, 2007
Hypoxia inducible factor 1-alpha expression as a factor predictive of efficacy of taxane/platinum chemotherapy in advanced primary epithelial ovarian cancerHidekatsu Nakai, Yoh Watanabe, Haruhiko Ueda, et al.
Pageof 7